novo nordisk glp 1 products GLP-1 ad war leads to lawsuit by Nordisk, claiming Eli Lilly misleads McKee's proposed FY2027 budget drops

Why the numbers work: 2.8% monthly attrition vs 6-8% industry average: lower hidden retraining costs over multi-year engagements 90% CSAT: fewer escalations, fewer repeat contacts, stronger patient experience metrics 5-year average client partnerships: onboarding investment amortizes over a much longer value cycle SOC 2, HIPAA, GDPR, ISO 27001 certified: compliance is built in, not bolted on after contracting

including a prior authorization protocol that requires chart documentation of a type 2 diabetes diagnosis based on a recent A1C (measurement of average blood sugar levels) equal to or greater than 6.5%

Whether youre managing diabetes, improving heart health, or pursuing sustainable weight goals, remember that wellness is a journey

The ranking is best read as the author's caution rather than as an established interaction severity

(For diabetics, the 12-month discontinuation rate was 35%.) When the drug is stopped, most of the health benefits derived from it are lost

Read more about: GLP-1s